Method for altering cell fate
Details for Australian Patent Application No. 2002245101 (hide)
International Classifications
Event Publications
13 February 2003 Application Open to Public Inspection
Published as AU-B-2002245101
5 July 2007 Application Accepted
Published as AU-B-2002245101
8 November 2007 Standard Patent Sealed
14 August 2008 Assignment Registered
Nucleotech, LLC The patent has been assigned to Kirin Pharma Kabushiki Kaisha
26 March 2009 Assignment Registered
Kirin Pharma Kabushiki Kaisha The patent has been assigned to Kyowa Hakko Kirin Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002245102-Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
2002245100-INSTRUMENTATION AND METHOD FOR INTERVERTEBRAL IMPLANT INSERTION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser